Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Cameroon

被引：0
|
作者：
Nkengafac, A. D. [1 ]
Tina, S. [1 ]
Sua, F. [1 ]
Mason, T. [1 ]
Auyuketta, N. [1 ]
Oben, S. [1 ]
机构：
[1] Inst Adv Med Sci, Buea, Cameroon
来源：
ANTIVIRAL THERAPY | 2007年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [41] Raltegravir has no residual antiviral activity in vivo against HIV-1 with resistance-associated mutations to this drug
    Wirden, Marc
    Simon, Anne
    Schneider, Luminita
    Tubiana, Roland
    Malet, Isabelle
    Ait-Mohand, Hocine
    Peytavin, Gilles
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (05) : 1087 - 1090
  • [42] Emergence of drug resistance-associated mutations in HIV-1 subtype C protease gene in north India
    Azam, Mohd
    Malik, Abida
    Rizvi, Meher
    Singh, Supriya
    Gupta, Poonam
    Rai, Arvind
    VIRUS GENES, 2013, 47 (03) : 422 - 428
  • [43] Emergence of drug resistance-associated mutations in HIV-1 subtype C protease gene in north India
    Mohd Azam
    Abida Malik
    Meher Rizvi
    Supriya Singh
    Poonam Gupta
    Arvind Rai
    Virus Genes, 2013, 47 : 422 - 428
  • [44] HIV-1 Molecular Epidemiology, Transmission Clusters and Transmitted Drug Resistance Mutations in Central Brazil
    Ortiz Tanaka, Tayana Serpa
    Leite, Thaysse Ferreira
    Freitas, Solange Zacalusni
    Cesar, Gabriela Alves
    de Rezende, Grazielli Rocha
    Campos Lindenberg, Andrea De Siqueira
    Guimaraes, Monick Lindenmeyer
    Coimbra Motta-Castro, Ana Rita
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [45] In vivo HIV-1 compartmentalisation: Drug resistance-associated mutation distribution
    Devereux, HL
    Burke, A
    Lee, CA
    Johnson, MA
    JOURNAL OF MEDICAL VIROLOGY, 2002, 66 (01) : 8 - 12
  • [46] Characteristics of molecular epidemiology and transmitted drug resistance among newly diagnosed HIV-1 infections in Lishui, China from 2020 to 2023
    Jinkai Li
    Jianhua Mei
    Jie Yu
    Xiaolei Chen
    Jianliang Zhu
    Jiaji Ye
    Deyong Zhang
    Dongqing Cheng
    Xiuying Chen
    Virology Journal, 22 (1)
  • [47] Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs
    Claudia Alteri
    Valentina Svicher
    Caterina Gori
    Roberta D'Arrigo
    Massimo Ciccozzi
    Francesca Ceccherini-Silberstein
    Marina Selleri
    Stefano Aviani Bardacci
    Massimo Giuliani
    Paola Elia
    Paola Scognamiglio
    Roberta Balzano
    Nicoletta Orchi
    Enrico Girardi
    Carlo Federico Perno
    BMC Infectious Diseases, 9
  • [48] Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: Evidence of major Drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B
    Ndembi, Nicaise
    Abraha, Awet
    Pilch, Heather
    Ichimura, Hiroshi
    Mbanya, Dora
    Kaptue, Lazare
    Salata, Robert
    Arts, Eric J.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (01) : 177 - 184
  • [49] Factors associated with a decrease in the prevalence of drug resistance in newly HIV-1 infected individuals in Montreal
    Routy, JP
    Machouf, N
    Edwardes, MD
    Brenner, BG
    Thomas, R
    Trottier, B
    Rouleau, D
    Tremblay, CL
    Côté, P
    Baril, JG
    Remis, RS
    Sékaly, RP
    Wainberg, MA
    AIDS, 2004, 18 (17) : 2305 - 2312
  • [50] HIV-1 resistance and trend analysis in newly diagnosed patients in Belgium
    Muyldermans, G.
    Sasse, A.
    ACTA CLINICA BELGICA, 2014, 69 (01) : 1 - 7
12345